A couple of interesting exerts from one of the articles on their website from June 2017 for those interested in the timeline...
"The company has already had informal meetings with US FDA to plan the first-in-human feasibility trial and will soon enter formal talks with the agency. It plans to start clinical trials in the US by the end of 2018."
"Twin Cities-area, Minnesota company is has almost closed its series A round of $8m, which it raised from "family and friends" and angel investors. The B round of financing, which will be include venture capital investments along with strategic investments from other device companies will total about $15m and hopefully be closed in early 2018, Thatcher said. The company will need at least some of the round B money to support clinical trials, he said"
Why 4C TMVR will win, page-3
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$14.25 |
Change
0.740(5.48%) |
Mkt cap ! $301.2M | |||
| Open | High | Low | Value | Volume |
| $13.60 | $14.25 | $13.35 | $309.6K | 22.39K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1150 | $14.10 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $14.25 | 314 | 1 |
View Market Depth
| Last trade - 16.10pm 09/08/2024 (20 minute delay) ? |
| AVR (ASX) Chart |